This page collects WhisperX intelligence signals tagged #eu pharma. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
Whispers from within the European Medicines Agency (EMA) suggest a pattern of data manipulation in clinical trials for several high-profile drugs. Sources indicate that certain contract research organizations (CROs) operating under lax oversight in Eastern Europe have been pressured by major pharmaceutical firms to 'op...
Whispers from Brussels suggest a systemic issue within the EU's pharmaceutical regulatory framework. Multiple sources within EMA-affiliated contract research organizations (CROs) indicate a pattern of 'data smoothing' and selective reporting in clinical trial submissions. This isn't outright fabrication, but rather a s...